Skip to main content
Ralph Deberardinis, MD, Medical Genetics, Dallas, TX

Ralph J Deberardinis MD

Clinical Biochemical Genetics, Clinical Genetics, Ph.D. Medical Genetics, Pediatric Medical Genetics


Associate Professor, Chief of Pediatric Genetics and Metabolism, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to View Full Profile
  • 5323 Harry Hines BlvdDallas, TX 75390

  • Phone+1 214-633-1803

  • Fax+1 214-648-5515

Dr. Deberardinis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics/Medical Genetics and Genomics, 2000 - 2005
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2000

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2008 - 2025
  • PA State Medical License
    PA State Medical License 2001 - 2008
  • Clinical Biochemical Genetics
    American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
  • Clinical Genetics and Genomics
    American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Clinical Trials

Publications & Presentations

Journal Articles

  • Gain‐of‐Function Variants in the ODC1 Gene Cause a Syndromic Neurodevelopmental Disorder Associated with Macrocephaly, Alopecia, Dysmorphic Features, and Neuroimaging ...  
    Sanjeev V Kothare, Farrah Rajabi, Annapurna Poduri, Lance H Rodan, Ralph J DeBerardinis, American Journal of Medical Genetics Part A
  • Genomic Regression Analysis of Coordinated Expression  
    Yang Xie, Ralph J DeBerardinis, Nature

Press Mentions

  • Children’s Research Institute Scientists Uncover Unique Pathway Tumors Use to Acquire Antioxidant Lipids
    Children’s Research Institute Scientists Uncover Unique Pathway Tumors Use to Acquire Antioxidant LipidsJune 11th, 2025
  • HMN 2025: How FDA-Designated Orphan Drug May Improve Radiation Efficacy in Lung Cancer
    HMN 2025: How FDA-Designated Orphan Drug May Improve Radiation Efficacy in Lung CancerMay 3rd, 2025
  • FDA-Designated Orphan Drug Could Increase Radiation Efficacy in Lung Cancer
    FDA-Designated Orphan Drug Could Increase Radiation Efficacy in Lung CancerMay 1st, 2025
  • Join now to see all

Grant Support

  • Human metabolic variation as a window into cancer initiation and progressionUT SOUTHWESTERN MEDICAL CENTER2017–2030
  • Metabolic Regulators Of Tumor Cell GrowthNational Cancer Institute2011–2012
  • Intermediary Metabolism In Tumor CellsNational Center For Research Resources2011
  • Imaging Of Hyperpolarized Substrates In Animal Models Of CancerNational Center For Research Resources2010
  • Metabolic Regulation In Growth Factor-Dependent CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
  • Metabolic Regulation In Growth Factor-Dependent CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2007

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: